Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,405-1,416 of 4,306
Behavioral study icon
CompletedNCT00990925

Lifestyle Modification for Weight Loss in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Drug study icon
CompletedNCT00132314

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Tuscaloosa
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Other study type icon
CompletedNCT07447960

LRFN5 and OLFM4 in Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Elâzığ
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Türkiye
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT02199743

Lurasidone Effects on Tissue Glutamate in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
Drug study icon
TerminatedNCT02796144

MEtformin and Lorcaserin for WeighT Loss in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Augusta
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Drug study icon
CompletedNCT02124811

Minocycline Augmentation to Clozapine

This summary needs review. Please check the official study record and contact the research team for details.

In Atlanta
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03621774

Mobile CBT for Negative Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In La Jolla
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Drug study icon
CompletedNCT00423943

Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 54 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03404219

Motivation and Skills Support (MASS)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Francisco
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Boston University Charles River Campus
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00261716

Motivational Interviewing to Improve Work Outcomes in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In West Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.